This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Biotransplant, Inc., Universitè Catholique De Louvain. Active years: 1999-2005.
Company Filing History:
3 out of 14 
2 out of 100 
Years Active: 1999-2005
Title: Mary E White-Scharf: Innovator in Immunology
Introduction
Mary E White-Scharf is a notable inventor based in Winchester, MA (US). She has made significant contributions to the field of immunology, particularly through her innovative work on antibodies. With a total of 3 patents, her research focuses on inhibiting T cell activation and proliferation, which has important implications for treating various immune-related conditions.
Latest Patents
Mary E White-Scharf's latest patents include the development of the LO-CD2a antibody and its uses for inhibiting T cell activation and proliferation. This invention relates to methods of using LO-CD2a antibodies or molecules that bind to the same epitope to prevent and inhibit immune responses in human patients. The administration of an effective amount of the LO-CD2a antibody can prevent or inhibit graft rejection, graft versus host disease, or autoimmune disease.
Career Highlights
Throughout her career, Mary has worked with prominent organizations such as Biotransplant, Inc. and Université Catholique De Louvain. Her work has been instrumental in advancing the understanding of immune responses and developing therapeutic strategies to manage them effectively.
Collaborations
Mary has collaborated with notable colleagues, including Dominique Latinne and Ruth A Kaplan. These partnerships have contributed to her success and the impact of her inventions in the field of immunology.
Conclusion
Mary E White-Scharf is a pioneering inventor whose work on LO-CD2a antibodies has the potential to transform treatments for immune-related diseases. Her contributions to immunology continue to inspire advancements in medical research and therapy.